KalVista Pharmaceuticals, Inc. (KALV)

NASDAQ: KALV · Real-Time Price · USD

26.66

+0.01 (0.04%)

At close: May 4, 2026, 4:00 PM EDT

26.74

+0.08 (0.30%)

Pre-market: May 5, 2026, 5:06 AM EDT

KalVista Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024
Net Income	-183.44	-126.64
Depreciation & Amortization	0.94	0.82
Stock-Based Compensation	12.29	21.92
Other Adjustments	2.27	-0.49
Changes in Accounts Payable	-4.97	4.32
Changes in Accrued Expenses	14.43	3.21
Changes in Unearned Revenue	10.56	-
Changes in Other Operating Activities	-4.98	7.64
Operating Cash Flow	-152.91	-89.23
Capital Expenditures	-0.43	-0.04
Purchases of Intangible Assets	-0.5	-0.4
Purchases of Investments	-30.57	-189.23
Proceeds from Sale of Investments	122.52	104.96
Investing Cash Flow	91.02	-84.72
Issuance of Common Stock	61.69	150.71
Net Common Stock Issued (Repurchased)	61.69	150.71
Other Financing Activities	98.04	-
Financing Cash Flow	159.73	150.71
Effect of Exchange Rate Changes on Cash and Cash Equivalents	2.64	-1.21
Net Cash Flow	100.48	-24.45
Free Cash Flow	-153.34	-89.27
Free Cash Flow Per Share	-3.09	-2.43
Levered Free Cash Flow	-167.9	-110.7
Unlevered Free Cash Flow	-176	-124.5

Updated Nov 11, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q